These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8727594)

  • 1. ELI's coming: expression library immunization and vaccine antigen discovery.
    Ulmer JB; Liu MA
    Trends Microbiol; 1996 May; 4(5):169-70; discussion 170-1. PubMed ID: 8727594
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological properties of recombinant HBsAg produced in yeast.
    Hauser P; Voet P; Simoen E; Thomas HC; Pêtre J; De Wilde M; Stephenne J
    Postgrad Med J; 1987; 63 Suppl 2():83-91. PubMed ID: 2446304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological properties of bacterial DNA.
    Pisetsky DS; Reich C; Crowley SD; Halpern MD
    Ann N Y Acad Sci; 1995 Nov; 772():152-63. PubMed ID: 8546388
    [No Abstract]   [Full Text] [Related]  

  • 4. DNA vaccination: antigen presentation and the induction of immunity.
    Shedlock DJ; Weiner DB
    J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant vector vaccines in vaccinology.
    Hilleman MR
    Dev Biol Stand; 1994; 82():3-20. PubMed ID: 7958480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Swinepox Virus for Veterinary Vaccine Development.
    Fan HJ; Lin HX
    Methods Mol Biol; 2016; 1349():163-75. PubMed ID: 26458836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to hepatitis B virus surface and core antigens in mice, monkeys, and pigs after Accell particle-mediated DNA immunization.
    Fuller JT; Fuller DH; McCabe D; Haynes JR; Widera G
    Ann N Y Acad Sci; 1995 Nov; 772():282-4. PubMed ID: 8546409
    [No Abstract]   [Full Text] [Related]  

  • 8. Protection against mycoplasma infection using expression-library immunization.
    Barry MA; Lai WC; Johnston SA
    Nature; 1995 Oct; 377(6550):632-5. PubMed ID: 7566175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The immunogenicity in mice enhanced significantly via prime-boost vaccination with DNA-based or recombinant vaccinia(Tiantan) viral-based H5N1 vaccine candidates containing multi-structural antigens].
    Wang W; Chen H; Deng Y; Yang Y; Yin X; Wang M; Zhou JF; Shu YL; Ruan L; Tan WJ
    Bing Du Xue Bao; 2011 Nov; 27(6):594-8. PubMed ID: 22263273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines.
    Cannas A; Naguleswaran A; Müller N; Eperon S; Gottstein B; Hemphill A
    Parasitology; 2003 Apr; 126(Pt 4):303-12. PubMed ID: 12741509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simian immunodeficiency virus DNA vaccine trial in macaques.
    Robinson HL; Lu S; Mustafa F; Johnson E; Santoro JC; Arthos J; Winsink J; Mullins JI; Montefiori D; Yasutomi Y
    Ann N Y Acad Sci; 1995 Nov; 772():209-11. PubMed ID: 8546394
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of antibodies against Salmonella typhi OmpC porin by naked DNA immunization.
    López-Macías C; López-Hernández MA; González CR; Isibasi A; Ortiz-Navarrete V
    Ann N Y Acad Sci; 1995 Nov; 772():285-8. PubMed ID: 8546410
    [No Abstract]   [Full Text] [Related]  

  • 13. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
    Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
    Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of recombinant DNA Plasmodium falciparum sporozoite vaccine?
    Grove DI
    Lancet; 1987 Jul; 2(8552):220. PubMed ID: 2885674
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessing CD4+ helper T-lymphocyte responses by lymphoproliferation.
    Quakyi IA; Ahlers JD
    Methods Mol Med; 2002; 72():369-83. PubMed ID: 12125133
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulatory issues in the use of DNA vaccines.
    Minor PD
    Ann N Y Acad Sci; 1995 Nov; 772():170-7. PubMed ID: 8546390
    [No Abstract]   [Full Text] [Related]  

  • 17. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.
    Lan J; Gao Z; Xiong H; Chuai X; Jin Y; Li J; Xian X; Liu G; Xie L; Zhang Y; Wang Y
    Vaccine; 2011 Sep; 29(40):6894-902. PubMed ID: 21803097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid matrix-antibody-antigen (SMAA) complexes for constructing multivalent subunit vaccines.
    Randall RE
    Immunol Today; 1989 Oct; 10(10):336-9. PubMed ID: 2679630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of intramuscular immunization with naked DNA.
    Donnelly JJ; Ulmer JB; Liu MA
    Ann N Y Acad Sci; 1995 Nov; 772():40-6. PubMed ID: 8546412
    [No Abstract]   [Full Text] [Related]  

  • 20. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
    Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
    Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.